Related Experiment Videos
Intra-articular glucocorticoids in early juvenile chronic arthritis
V E Honkanen1, J K Rautonen, P M Pelkonen
1Children's Hospital, University of Helsinki, Finland.
Insights
Triamcinolone injections significantly improved remission duration in children with juvenile chronic arthritis and knee synovitis compared to methylprednisolone. Synovial fluid cell counts also influenced remission length.
Area of Science:
- Pediatric Rheumatology
- Orthopedic Surgery
- Pharmacology
Background:
- Juvenile chronic arthritis (JCA) frequently affects the knee joint, causing synovitis.
- Intra-articular glucocorticoid injections are a common treatment for early-phase knee synovitis in JCA.
- Optimizing treatment choice and understanding prognostic factors are crucial for long-term remission.
Purpose of the Study:
- To compare the efficacy of triamcinolone versus methylprednisolone for intra-articular injections in early knee synovitis in JCA.
- To investigate the association between synovial fluid characteristics and remission duration.
Main Methods:
- A study involving 79 children with JCA receiving intra-articular glucocorticoid injections for knee synovitis.
- Randomized treatment allocation with half of injections within six months of disease onset.
- Multivariate analysis to assess the relationship between synovial fluid polymorphonuclear leucocyte proportion (SF-PMN%) and remission length.
Main Results:
- Triamcinolone treatment was associated with a significantly higher probability of sustained remission compared to methylprednisolone (p < 0.0005).
- A high synovial fluid polymorphonuclear leucocyte proportion (SF-PMN%) was significantly linked to shorter remission durations (chi-square = 8.81, p < 0.005).
- The superior efficacy of triamcinolone remained evident two years post-injection.
Conclusions:
- Triamcinolone demonstrates superior efficacy over methylprednisolone in achieving prolonged remission for early knee synovitis in JCA.
- Synovial fluid inflammatory markers, specifically SF-PMN%, are important predictors of treatment outcome and remission duration.
Abstract:
The efficacy of intra-articular glucocorticoid injections in the early phase of knee joint synovitis was studied in 79 children with juvenile chronic arthritis (42 girls and 37 boys). Half of the injections were given within the first six months from the onset of the disease. The probability of a patient staying in remission was much higher in triamcinolone-treated patients than in patients receiving methylprednisolone (p < 0.0005, Breslow statistics). Using multivariate analysis there was a significant association between the length of remission and the synovial fluid polymorphonuclear leucocyte proportion (SF-PMN%). Patients with a high SF-PMN% tended to have shorter remissions than those with a low SF-PMN% (improvement of the fit in stepwise model: chi-square = 8.81, p < 0.005). The difference between triamcinolone and methylprednisolone groups was still clearly evident two years after injection.